Skip to content
Screener

NeoGenomics NEO Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Biodesix, Inc. logo
Biodesix, Inc.BDSX
$6.41M-10.4%
Myriad Genetics logo
Myriad GeneticsMYGN
Labcorp Holdings logo
Labcorp HoldingsLH
Quest Diagnostics logo
Quest DiagnosticsDGX
Personalis, Inc. logo
Personalis, Inc.PSNL
Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
Net income$2.2M+105%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$2.13B+184%
Enterprise value$2.43B+265%
P/S2.8×+1.7×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001077183-26-000059
Line item(unaudited)June 30, 2026December 31, 2025
Financing lease right-of-use assets6,65354
Intangible assets, net271,262286,528
Goodwill523,995524,344
Other assets9,3119,340
Total non-current assets970,765983,544
Total assets$1,352,243$1,359,830
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities

Item 1. Financial Statements (unaudited)

FAQ

What is NeoGenomics's deferred tax assets and other non-current assets?
NeoGenomics (NEO) reported deferred tax assets and other non-current assets of $9.31M in Q2 2026.
How has NeoGenomics's deferred tax assets and other non-current assets changed year-over-year?
NeoGenomics's deferred tax assets and other non-current assets increased by 30.6% year-over-year, from $7.13M to $9.31M.
What is the long-term trend for NeoGenomics's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), NeoGenomics's deferred tax assets and other non-current assets has grown at a 15.8% compound annual growth rate (CAGR), from $4.5M to $9.39M.

Ask your AI about NeoGenomics's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude